Explore more publications!
Missouri Health Digest
Got News to Share?

Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 8, 2025

“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List
December 8, 2025

“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List

Indeterminate GlobeNewswire
Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting
December 8, 2025

Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting
December 8, 2025

Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
December 8, 2025

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

Indeterminate GlobeNewswire
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
December 8, 2025

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in…
December 8, 2025

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in…

Indeterminate GlobeNewswire
Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025
December 8, 2025

Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025

Indeterminate GlobeNewswire
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
December 8, 2025

Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025

Indeterminate GlobeNewswire
Protara Announces Closing of $75 Million Public Offering
December 8, 2025

Protara Announces Closing of $75 Million Public Offering

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
December 8, 2025

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock
December 8, 2025

Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 8, 2025

Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Indeterminate GlobeNewswire
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
December 8, 2025

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

Indeterminate GlobeNewswire
Kymera Therapeutics Announces Proposed Public Offering
December 8, 2025

Kymera Therapeutics Announces Proposed Public Offering

Indeterminate GlobeNewswire
Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants
December 8, 2025

Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants

Indeterminate GlobeNewswire
Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri
December 8, 2025

Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri

Indeterminate GlobeNewswire
Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook
December 8, 2025

Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook

Indeterminate GlobeNewswire
Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting
December 8, 2025

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting

Indeterminate GlobeNewswire
A-Team Home Care Turns Nine and Shines—Earning Philadelphia100 Top-20, Philadelphia Inquirer's Best in Philly Home Care, and 2025 Best Employer & Senior Care Titles in Bucks Happenings
December 8, 2025

A-Team Home Care Turns Nine and Shines—Earning Philadelphia100 Top-20, Philadelphia Inquirer's Best in Philly Home Care, and 2025 Best Employer & Senior Care Titles in Bucks Happenings

Indeterminate GlobeNewswire
KPC Health’s Anaheim Global Medical Center and South Coast Global Medical Center Earn ‘A’ Hospital Safety Grades from The Leapfrog Group
December 8, 2025

KPC Health’s Anaheim Global Medical Center and South Coast Global Medical Center Earn ‘A’ Hospital Safety Grades from The Leapfrog Group

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions